Research Analysts’ Recent Ratings Changes for Sanofi SA (SAN)

Several analysts have recently updated their ratings and price targets for Sanofi SA (EPA: SAN):

  • 2/9/2017 – Sanofi SA was given a new €96.00 ($102.13) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 2/9/2017 – Sanofi SA was given a new €81.00 ($86.17) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “neutral” rating on the stock.
  • 2/8/2017 – Sanofi SA was given a new €91.00 ($96.81) price target on by analysts at Morgan Stanley. They now have a “buy” rating on the stock.
  • 2/6/2017 – Sanofi SA had its “sell” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 2/3/2017 – Sanofi SA was given a new €87.00 ($92.55) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 1/31/2017 – Sanofi SA had its “sell” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 1/24/2017 – Sanofi SA was given a new €81.00 ($86.17) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “neutral” rating on the stock.
  • 1/20/2017 – Sanofi SA was given a new €80.00 ($85.11) price target on by analysts at Jefferies Group LLC. They now have a “neutral” rating on the stock.
  • 1/12/2017 – Sanofi SA had its “sell” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 1/9/2017 – Sanofi SA was given a new €96.00 ($102.13) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 1/6/2017 – Sanofi SA was given a new €77.00 ($81.91) price target on by analysts at Sanford C. Bernstein. They now have a “neutral” rating on the stock.
  • 1/6/2017 – Sanofi SA was given a new €83.00 ($88.30) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “neutral” rating on the stock.
  • 1/6/2017 – Sanofi SA had its “neutral” rating reaffirmed by analysts at Citigroup Inc..
  • 1/5/2017 – Sanofi SA was given a new €71.00 ($75.53) price target on by analysts at J P Morgan Chase & Co. They now have a “sell” rating on the stock.
  • 12/19/2016 – Sanofi SA was given a new €76.00 ($80.85) price target on by analysts at Jefferies Group LLC. They now have a “neutral” rating on the stock.

Shares of Sanofi SA (EPA:SAN) traded up 0.47% during midday trading on Tuesday, reaching €80.76. The company’s stock had a trading volume of 1,265,819 shares. The stock has a 50-day moving average price of €25.50 and a 200 day moving average price of €25.74. The stock has a market capitalization of €103.61 billion and a PE ratio of 22.07. Sanofi SA has a 52 week low of €62.50 and a 52 week high of €81.05.

Sanofi SA, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. It operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/research-analysts-recent-ratings-changes-for-sanofi-sa-san/1660309.html

Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *